1. Home
  2. ALVR vs VSTE Comparison

ALVR vs VSTE Comparison

Compare ALVR & VSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • VSTE
  • Stock Information
  • Founded
  • ALVR 2013
  • VSTE 2009
  • Country
  • ALVR United States
  • VSTE Australia
  • Employees
  • ALVR N/A
  • VSTE N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • VSTE
  • Sector
  • ALVR Health Care
  • VSTE
  • Exchange
  • ALVR Nasdaq
  • VSTE Nasdaq
  • Market Cap
  • ALVR 87.7M
  • VSTE 30.0M
  • IPO Year
  • ALVR 2020
  • VSTE N/A
  • Fundamental
  • Price
  • ALVR $0.94
  • VSTE $1.89
  • Analyst Decision
  • ALVR Sell
  • VSTE
  • Analyst Count
  • ALVR 5
  • VSTE 0
  • Target Price
  • ALVR $1.00
  • VSTE N/A
  • AVG Volume (30 Days)
  • ALVR 155.6K
  • VSTE 14.1K
  • Earning Date
  • ALVR 11-04-2024
  • VSTE 01-01-0001
  • Dividend Yield
  • ALVR N/A
  • VSTE N/A
  • EPS Growth
  • ALVR N/A
  • VSTE N/A
  • EPS
  • ALVR N/A
  • VSTE N/A
  • Revenue
  • ALVR N/A
  • VSTE $342,000.00
  • Revenue This Year
  • ALVR N/A
  • VSTE N/A
  • Revenue Next Year
  • ALVR N/A
  • VSTE N/A
  • P/E Ratio
  • ALVR N/A
  • VSTE N/A
  • Revenue Growth
  • ALVR N/A
  • VSTE N/A
  • 52 Week Low
  • ALVR $0.58
  • VSTE $0.83
  • 52 Week High
  • ALVR $2.49
  • VSTE $12.00
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 69.10
  • VSTE 55.09
  • Support Level
  • ALVR $0.74
  • VSTE $0.83
  • Resistance Level
  • ALVR $0.91
  • VSTE $1.09
  • Average True Range (ATR)
  • ALVR 0.06
  • VSTE 0.10
  • MACD
  • ALVR 0.01
  • VSTE 0.03
  • Stochastic Oscillator
  • ALVR 94.50
  • VSTE 92.08

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About VSTE Vast Renewables Limited

Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.

Share on Social Networks: